[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355317-105":59,"doc-detail-355317-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","germline-genetic-profiling-utilizing-multigene-panel-testing-in-jordanian-patients-with-pancreatic-cancer-a-comprehensive-cancer-center-experience","Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer - a comprehensive cancer center experience","","Pancreatic ductal adenocarcinoma (PDAC) causes substantial cancer mortality worldwide, and 5%–10% of cases can reflect inherited genetic alterations. However, germline variant data among Arab patients with PDAC remain limited. This prospective study at King Hussein Cancer Center evaluated multigene panel testing outcomes in adult PDAC patients in Amman, Jordan, including cascade family testing for relatives with positive results. Results summarized frequencies of pathogenic/likely pathogenic findings and communication gaps. Universal testing and improved result sharing are emphasized.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-genetic-profiling-utilizing-multigene-panel-testing-in-jordanian-patients-with-pancreatic-cancer-a-comprehensive-cancer-center-experience/355317/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-genetic-profiling-utilizing-multigene-panel-testing-in-jordanian-patients-with-pancreatic-cancer-a-comprehensive-cancer-center-experience/355317.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What proportion of PDAC is linked to inherited genetic alterations according to the study background?","Question",{"text":112,"@type":113},"The background states that 5% to 10% of PDACs are attributable to inherited genetic alterations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was germline genetic testing conducted in this study?",{"text":117,"@type":113},"Adult PDAC patients at King Hussein Cancer Center underwent multigene panel (MGP) testing using standard or investigational panels, and cascade family testing was offered to relatives of patients with positive results.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study report about positive germline mutations and communication with relatives?",{"text":121,"@type":113},"Among 211 patients, 22 (10.4%) had positive mutations, with pathogenic/likely pathogenic variants and an increased-risk APC allele. Half of patients with positive findings communicated results to relatives, and 69.2% of tested relatives with their patients’ positive results were positive.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355317,1790193663,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Abdel-Razeq etal. BMC Cancer (2026) 26:370 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15669-0](https://doi.org/10.1186/s12885-026-15669-0)  \nRESEARCH Open Access  \nGermline genetic profiling utilizing   \nmultigene panel testing in Jordanian patients with pancreatic cancer: a comprehensive cancer center experience  \nHikmat Abdel-Razeq1,2*, Yacob Saleh1, Hira Bani Hani1, Rashid Abdel-Razeq3, Issa Mohamad4, Baha Sharaf1, Faris Tamimi1, Hala Abu-Jaish1, Areej Al-Atary5, Anisa Aljabri4, Rahaf Alnajjar4, Mohammd Sammour1, Ameed Ghanem1, Rula Amarin1 and Tala Awabdeh1  \nAbstract  \nBackground Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths worldwide. Between 5% and 10% of PDACs are attributable to inherited genetic alterations, identification of which may enhance targeted screening and inform treatment decisions. Data on germline variants among Arab patients with PDAC are lacking.  \nMethods This prospective study included adult patients with PDAC treated at King Hussein Cancer Center in Amman, Jordan. Patients underwent multigene panel (MGP) testing using either standard or investigational panels. Cascade family testing was offered to relatives of patients with positive results. Germline testing results were classified as benign (negative), pathogenic/likely pathogenic (P/LP) (positive) or variants of uncertain significance (VUS) .  \nResults A total of 211 patients, all of whom had PDAC as their first cancer diagnosis upon enrollment, were included in the analysis. The median age at diagnosis was 59 years, and 63. 0% were males. In total, 22 (10 .4%) patients had positive mutations; 14 (6 . 6%) as pathogenic/likely pathogenic (P/LP) variants, mostly in BRCA2 (n = 8), while 8 others (3 . 8%) had increased risk allele in APC. Other variants identified included ATM, CFTR, CHEK2, BRCA1, and MSH6 . Half (n = 11, 50 . 0%) of patients with P/LP variants or APC increased risk allele communicated results with their relatives; 18 (69 . 2%) of 26 relatives tested had positive results.  \nConclusions Our study underscores the relevance of PDAC germline genetic testing among the Arab population. Given its clinical implications for screening and management, universal testing should be advocated. Communicating test results with at-risk relatives, despite its importance, remains suboptimal and warrants further investigation. Keywords Pancreatic cancer, PDAC, BRCA, Germline genetic testing  \n*Correspondence: Hikmat Abdel-Razeq[habdelrazeq@khcc.jo](habdelrazeq@khcc.jo)  \n1Section of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman 11941, Jordan 2Department of Internal Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan  \n3Department of Internal Medicine, Fairview Hospital Program, Cleveland Clinic Foundation, Cleveland 44111, OH, USA  \n4Department of Radiation Therapy, King Hussein Cancer Center, Amman 11941, Jordan  \n5Department of Nursing, King Hussein Cancer Center, Amman, Jordan  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy o","cbCaioFZD4jabtZZ","https://ap.wps.com/l/cbCaioFZD4jabtZZ","pdf",1605346,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What proportion of PDAC is linked to inherited genetic alterations according to the study background?\",\"answer\":\"The background states that 5% to 10% of PDACs are attributable to inherited genetic alterations.\"},{\"question\":\"How was germline genetic testing conducted in this study?\",\"answer\":\"Adult PDAC patients at King Hussein Cancer Center underwent multigene panel (MGP) testing using standard or investigational panels, and cascade family testing was offered to relatives of patients with positive results.\"},{\"question\":\"What did the study report about positive germline mutations and communication with relatives?\",\"answer\":\"Among 211 patients, 22 (10.4%) had positive mutations, with pathogenic/likely pathogenic variants and an increased-risk APC allele. Half of patients with positive findings communicated results to relatives, and 69.2% of tested relatives with their patients’ positive results were positive.\"}]","Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer - a comprehensive cancer center experience | PDF",1790117730,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/826ffdc3ff6db4ec9abffd1edc80cff4.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bff15e6c334e4d5f785dd140725ae589.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07308953cbcbbfb6c6db516daa26e0f1.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63c483daeab2b0e457d476a151d4f387.webp",980,1306]